|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALPHARMA INC, 10-Q, 2000-11-14 |
Next: ALPHARMA INC, 10-Q, EX-3, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 95,583
<SECURITIES> 0
<RECEIVABLES> 270,250
<ALLOWANCES> 0
<INVENTORY> 239,336
<CURRENT-ASSETS> 618,041
<PP&E> 507,285
<DEPRECIATION> 183,166
<TOTAL-ASSETS> 1,611,851
<CURRENT-LIABILITIES> 233,543
<BONDS> 371,826
0
0
<COMMON> 8,093
<OTHER-SE> 814,723
<TOTAL-LIABILITY-AND-EQUITY> 1,611,851
<SALES> 662,751
<TOTAL-REVENUES> 662,751
<CGS> 360,460
<TOTAL-COSTS> 360,460
<OTHER-EXPENSES> 203,147
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 35,237
<INCOME-PRETAX> 59,487
<INCOME-TAX> 19,783
<INCOME-CONTINUING> 39,704
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 39,704
<EPS-BASIC> 1.19
<EPS-DILUTED> 1.11
</TABLE>
|
|